Jaguar Health (JAGX) EBITDA Margin Growth (1y) (2016 - 2026)
Jaguar Health (JAGX) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
47,575.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
47,575.00 |
| Dec 31, 2025 |
-42,417.00 |
| Sep 30, 2025 |
-112.00 |
| Jun 30, 2025 |
-428.00 |
| Mar 31, 2025 |
-7,609.00 |
| Dec 31, 2024 |
9,611.00 |
| Sep 30, 2024 |
7,872.00 |
| Jun 30, 2024 |
3,827.00 |
| Mar 31, 2024 |
2.15 Mn |
| Dec 31, 2023 |
1.93 Mn |
| Sep 30, 2023 |
179.00 |
| Jun 30, 2023 |
-8,096.00 |
| Mar 31, 2023 |
3.69 Mn |
| Dec 31, 2022 |
-1.91 Mn |
| Sep 30, 2022 |
119,838.00 |
| Jun 30, 2022 |
283,360.00 |
| Mar 31, 2022 |
-5.81 Mn |
| Dec 31, 2021 |
-45,101.00 |
| Sep 30, 2021 |
-131,779.00 |
| Jun 30, 2021 |
5.73 Mn |
